Letter: not the end of the role of anti-viral therapy in ulcerative colitis with cytomegalovirus reactivation - authors' reply

被引：0
|
作者：
Delvincourt, M. [1 ]
Sokol, H. [1 ,2 ,3 ]
机构：
[1] Assistance Publ Hopitaux Paris & Paris VI Univ, St Antoine Hosp, Dept Gastroenterol, Paris, France
[2] Univ Paris 06, Laboratoire INSERM U1057 UMR CNRS 7203, Paris, France
[3] Commensal & Probiot Host Interact Lab, UMR 1319 Micalis, Jouy En Josas, France
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2014年 / 39卷 / 10期
关键词：
INFECTION;
D O I：
10.1111/apt.12722
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1247 / 1248
页数：2
相关论文
共 50 条
  • [41] HBcrAg, pg RNA and HBsAg dynamically supervise the seroconversion of HBsAg with anti-viral therapy "Loss of HBsAg" maybe not a good end-point of anti-viral therapy
    Ma, Guanghua
    Lou, Bin
    Lv, Feifei
    Zhao, Dejian
    Chen, Hui
    Ye, Xianfei
    Chen, Yu
    CLINICA CHIMICA ACTA, 2020, 501 : 264 - 269
  • [42] Editorial: Obesity and Outcomes on Advanced Therapy in Ulcerative Colitis-The Fat of the Matter: Authors' Reply
    Desai, Aakash
    Sehgal, Priya
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025,
  • [43] Editorial: anti-viral therapy for prevention of perinatal HBV transmission - extending therapy beyond birth and the risk of post-partum flare; authors' reply
    Nguyen, V.
    Levy, M. T.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (01) : 116 - 116
  • [44] Letter: how can we reduce mortality in elderly patients with acute severe ulcerative colitis? Authors' reply
    Dong, Catherine
    Metzger, Marie
    Holsbo, Einar E.
    Perduca, Vittorio
    Carbonnel, Franck
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (12) : 1445 - 1446
  • [45] Letter: reduction in chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low-risk patients - more questions than answers. Authors' reply
    Lin, D.
    Yang, H. -I.
    Hoang, J.
    Nguyen, M. H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (01) : 186 - 187
  • [46] Editorial: central obesity is a risk factor for hepatocellular carcinoma in Asian patients with chronic hepatitis B on anti-viral therapy-authors' reply
    Fan, Rong
    Hou, Jinlin
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (05) : 724 - 725
  • [47] Letter: anti-CTLA-4-associated colitis and inflammatory bowel disease pathogenesis - authors' reply
    Gupta, A.
    De Felice, K. M.
    Loftus, E. V., Jr.
    Khanna, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (08) : 1032 - 1033
  • [48] Intensified infliximab induction therapy for steroid-refractory acute severe ulcerative colitis - Authors' reply
    Suen, Christopher F. D. Li Wai
    Choy, Matthew C.
    Con, Danny
    De Cruz, Peter
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2025, 10 (01): : 19 - 19
  • [49] Editorial: Sequencing rescue therapy for acute severe ulcerative colitis-Ready for revision? Authors' reply
    Garcia, Maria Jose
    Gisbert, Javier P.
    Chaparro, Maria
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (10) : 1298 - 1299
  • [50] Letter: is measurement of faecal biomarkers helpful for the early diagnosis and prediction of pouchitis after proctocolectomy for ulcerative colitis? Authors' reply
    Kayal, Maia
    Ungaro, Ryan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (01) : 190 - 190
12345